Sleep Disorders Trial, Recruiting NCT03998020 Sponsor: University Hospital, Montpellier Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT03998020
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been experiencing ongoing, long-term excessive sleepiness, which has been identified by a sleep specialist and requires further objective testing at the Centre de Hypersomnias Rares
  • People who may or may not have already received a formal diagnosis of a chronic sleep disorder
  • People who are currently being treated for a chronic sleep disorder, or who are not yet receiving treatment
  • People who speak and understand French
  • People who are covered by a social security system
  • People who do not have an active infectious or inflammatory illness

Who may not be able to join:

  • People who are currently under a form of legal detention or are not free in their movements
  • People who are living in a medical or care institution
  • People who are legally considered a "protected adult" under the law (confirm with trial site)
  • People who are not covered by a social security system
  • People who do not wish to take part in the study protocol

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0033467330913

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2020
Est. completion
16 June 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Severity of somnolence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov